🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsSmall molecule vs peptide GLP-1 agonists — anyone have experience? Page 7

Small molecule vs peptide GLP-1 agonists — anyone have experience?

jason_paloalto Thu, Sep 18, 2025 at 10:31 PM 33 replies 1,842 viewsPage 7 of 7
adam_van
Member
212
890
Nov 2024
Vancouver, CA
Nov 22, 2025 at 2:23 AM#31
PeptideSynthNJ said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

This answered a question I did not know how to ask.

19 19FranDenver, Dr.BariatricHTX, LindaRN_retired and 16 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Nov 27, 2025 at 1:45 AM#32

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

18 18tammy_FL, Dr.LipidDallas, alex_tucson and 15 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
Dec 2, 2025 at 1:10 AM#33
claudia_zurich said:
The useful move here is to separate what is established from what is widely repeated.

Second this.

Last edited: Dec 2, 2025 at 2:10 AM
17 17LibrarianMeg, bri_stats, pete_manc_UK and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Dec 7, 2025 at 12:38 AM#34
claudia_zurich said:
The useful move here is to separate what is established from what is widely repeated.

Coming at claudia_zurich’s question from a different direction. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

16 16Dr.PulmRoch, maya_sedona, stefan_berlin and 13 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Dec 12, 2025 at 12:09 AM#35

One concrete data point for the thread. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

15 15RickReta_CO, PharmHunterJen, TomTeleRx and 12 others
Reply Quote Save Share Report
1567

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register